Browse 19 Pharmaceutical companies funded by Novo Holdings. See funding amounts, founder contacts, and investment details.
Mirum Pharmaceuticals is a biopharmaceutical company focused on the development and commercialization of therapies.
CoultreonBiopharma is developing best-in-class therapeutics that target clinically validated pathways in immunology and metabolic illnesses.
Spruce Biosciences is a biopharmaceutical company developing therapies for rare diseases that target the endocrine system.
Hemab is a clinical-stage biotech company that develops prophylactic biologic therapies for underserved bleeding and thrombotic.
Avalyn Pharma is a biopharma company developing therapies for the treatment of idiopathic pulmonary fibrosis and other respiratory diseases.
Reunion Neuroscience is a clinical-stage pharmaceutical company developing therapeutic solutions for underserved mental health conditions.
Tribune Therapeutics specializes in building promising pipeline of novel medicines to treat patients with a wide range of fibrotic diseases.
Orbis Medicines is a novel macrocyclic chemistry and computational platform for oral macrocycle drug discovery.
Convergent Therapeutics is a pharmaceutical company that focuses on developing radiopharmaceutical therapies for prostate cancer.
Draupnir Bio is developing a new type of cholesterol-lowering medicine which prevents blood clots in the heart.
Bluejay Therapeutics is a private biopharmaceutical company focused on the development of cures for infectious diseases.
Hoba Therapeutics is developing a new therapeutic protein for the treatment of neuropathic pain.
NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.
Muna Therapeutics discovers and develops therapies that slow or stop neurodegenerative diseases such as alzheimer’s and parkinson's.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
Augustine Therapeutics is discovering and developing innovative medicines for the treatment of neuromuscular and neurodegeneratives diseases
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.
Exscientia is a pharmatech company that uses an end-to-end AI platform to design and discover new drugs.
Arcellx develops engineered cell-based immunotherapies for the treatment of cancer and other serious diseases.
View all companies funded by Novo Holdings across every industry and funding stage.
View Full Novo Holdings Portfolio